文献速递中医内科中药与中成药合理使用

三七总皂苷抗代谢综合征的作用与机制:网络药理学研究

Uncovering the effect and mechanism of Panax notoginseng saponins on metabolic syndrome by network pharmacology strategy.
PubMed 文献 · J Ethnopharmacol · 2022-09-02

该研究结合体内外实验与网络药理学,评估三七总皂苷(PNS)对高脂饮食诱导的代谢综合征(MetS)小鼠的作用及机制。PNS可减轻体重、改善脂肪分布与糖代谢紊乱、减轻非酒精性脂肪肝,并促进棕色脂肪产热及白色脂肪米色化。机制上PNS通过ERK和p38MAPK而非JNK信号通路发挥抗MetS效应。

要点

  • PNS可改善高脂饮食诱导小鼠的MetS,包括减重、改善糖代谢和脂肪肝。
  • PNS增强棕色脂肪产热并诱导白色脂肪米色化,增加能量消耗。
  • PNS抗MetS效应由ERK和p38MAPK介导,不依赖JNK通路。

核心结论

  • PNS通过MAPK介导的脂肪产热激活对代谢综合征发挥保护作用,可能成为潜在治疗药物。

研究设计与样本

  • 体内使用正常C57BL/6J小鼠和高脂饮食诱导的MetS小鼠评估PNS抗MetS效应。
  • 体外使用成熟3T3-L1脂肪细胞验证信号通路。
  • 计算方面采用网络药理学预测潜在机制。

主要发现

  • PNS改善MetS,表现为体重减轻、肥胖减少、脂肪分布改善、糖代谢紊乱纠正及NAFLD减轻。
  • PNS促进能量消耗,显著增强棕色脂肪组织(BAT)产热,诱导白色脂肪组织(WAT)米色化。
  • 网络药理学鉴定307个候选靶点,富集于肝脏组织和脂肪细胞的MAPK信号通路。
  • 体外验证证实ERK和p38MAPK介导PNS抗MetS效应,而非JNK信号通路。

关键数值与推荐

  • HPLC用于确认PNS中皂苷的百分比。
  • 网络药理学鉴定307个候选靶点,富集于MAPK信号通路。

临床怎么用

  • PNS可能作为代谢综合征的潜在治疗药物,尤其针对肥胖、糖代谢紊乱和NAFLD。
  • 其作用机制涉及激活脂肪产热,可考虑用于能量消耗不足相关的代谢异常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Metabolic syndrome (MetS) is a cluster of disease centered on obesity, which is the result of stagnation of liver qi according to traditional Chinese medicine. Panax notoginseng is a traditional Chinese herbal medicine, entering liver and stomach meridians and dissipating blood stasis, in which panax notoginseng saponins (PNS) are the main active components. However, its effects and mechanism on metabolic syndrome has not been revealed yet. AIM OF STUDY: To evaluate the anti-MetS effect of PNS, including body weight and adiposity, glucose metabolism and non-alcoholic fatty liver disease (NAFLD), as well as to explore the mechanism and signaling pathway of PNS on MetS effect. MATERIALS AND METHODS: HPLC was utilized to affirm the percentages of saponins in PNS. In vivo, normal C57BL/6J mice and high-fat diet (HFD)-induced MetS mice were used to evaluate anti-MetS effect of PNS. Body weight, food and water intake were recorded. NMR imager was used for NMR imaging and lipid-water analysis. Blood glucose detection, glucose and insulin tolerance test were performed to evaluate glucose metabolism. Biochemical indexes analysis and histopathological staining were used to evaluate the effect on NAFLD. The expressions of mRNA and proteins related to thermogenesis in adipose tissue were determined using real-time PCR and Western blot. In silico, network pharmacology was utilized to predict potential mechanism. In vitro, matured 3T3-L1 adipocyte was used as subject to confirm the signaling pathway by Western blot. RESULTS: We determined the content of PNS component by HPLC. In vivo, PNS could improve metabolic syndrome with weight loss, reduction of adiposity, improvement of adipose distribution, correction of glucose metabolism disorder and attenuation of NAFLD. Mechanismly, PNS boosted energy exhaustion and dramatically enhanced thermogenesis in brown adipose tissue (BAT), induced white adipose tissue (WAT) browning. In silico, utilizing network pharmacology strategy, we identified 307 candidate targets which were enriched in MAPK signaling pathway specifically in liver tissue and adipocyte. In vitro validation confirmed ERK and p38MAPK mediated anti-MetS effects of PNS, not JNK signaling pathway. CONCLUSION: PNS exerted protective effect on metabolic syndrome through MAPK-mediated adipose thermogenic activation, which may serve as a prospective therapeutic drug for metabolic syndrome.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Ma P, Wang Z, et al. Uncovering the effect and mechanism of Panax notoginseng saponins on metabolic syndrome by network pharmacology strategy. J Ethnopharmacol. 2022. PMID: 36058479. doi:10.1016/j.jep.2022.115680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。